Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Flexible Manufacturing

Catalent's launch of Safinamide

Safinamide is the first new molecule in 20 years to be used in the treatment of Parkinson’s.

Zambon s.p.A. entrusted Catalent as its partner for timely development and launch of Safinamide under the brand name Xadago® to a worldwide target market.

More About This Company